Background Thrombosis is reported to occur more often among patients with COVID‐19
than otherwise expected in the setting of viral pneumonia and sepsis. Systemic inflammatory …

Background: Coronavirus disease 2019 (COVID-19) reportedly causes venous
thromboembolism (VTE), but the status of this complication in Japan was unclear. Methods …

While acute respiratory infections are known to increase thrombosis risk [1], the incidence of
venous thromboembolic events (VTE) in patients with coronavirus disease 2019 (COVID-19) …

Objectives Coronavirus disease 2019 (COVID-19) can lead to systemic coagulation
activation and thrombotic complications including venous thromboembolism. This study …

Venous thromboembolic complications have emerged as serious sequelae in COVID-19
infections. This article summarizes the most current information regarding pathophysiology …

Although COVID-19 has been reported to be associated with high rates of venous
thromboembolism (VTE), the risk of VTE and bleeding after hospitalization for COVID-19 …

Previous studies that assessed risk factors for venous thromboembolism (VTE) in COVID-19
patients have shown inconsistent results. Our aim was to investigate VTE predictors by both …

Abstract Coronavirus disease 2019 (COVID-19) has affected more than 6 million patients
worldwide. Deep venous thrombosis (DVT) has been increasingly recognized complication …

Background: Coronavirus Disease 2019 (COVID-19) is associated with Coagulopathy
(CAC) and Venous Thromboembolism (VTE). These are well-reported complications of …

Introduction COVID-19 may predispose to both venous and arterial thromboembolism due to
excessive inflammation, hypoxia, immobilisation and diffuse intravascular coagulation …